Minimaal invasieve metastase gerichte therapie voor prostaatkankerpatiënten met beperkte metastasen: een multicenter gerandomizeerde fase II - studie.
Engineering the tumor immune microenvironment in colorectal peritoneal metastases by locoregional delivery of toll like receptor agonists
Phase II Study of isolated lung perfusion combined with pulmonary metastasectomy for the treatment of patients with operable lung metastases from colorectal carcinoma, osteosarcoma or soft tissue sarcoma.
Renal cell carcinoma with synchronous metastasis to the calcaneus and metachronous metastases to the ovary and gallbladder
Renal cell carcinoma with synchronous metastasis to the calcaneus and metachronous metastases to the ovary and gallbladder
GENOMIC ANALYSIS OF MULTIPLE PROSTATE CANCER METASTASES HIGHLIGHTS METASTASIS FROM LOW-GRADE CANCER FOCI AND DYNAMIC ADAPTATIONS TO THERAPY
Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatment
Ribociclib (RIB) plus letrozole (LET) in patients (pts) with visceral metastases (VM) or bone-only metastases (BOM) in hormone receptor-positive (HR plus ), human epidermal growth factor receptor-2-negative (HER2-) advanced breast cancer (ABC): Subgroup a
Targeting quorum-sensing peptides for diagnosis, treatment and/or prevention of colorectal cancer metastasis